Takeda Cashed In From Delay Of Generic IBS Drug, Jury Told
Drug buyers urged a Massachusetts federal jury on Thursday to find that Takeda Pharmaceuticals conspired with another drugmaker to keep a generic version of anticonstipation drug Amitiza off the market in...To view the full article, register now.
Already a subscriber? Click here to view full article